CUMBERLAND PHARMACEUTICALS INC (CPIX) — Institutional Holders, Q2 2026

32 institutional investment managers reported a CPIX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $16.0M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CPIX in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

8

Added to

10

Trimmed

7

Sold out

5

Biggest buyers

  1. CITADEL ADVISORSAdded · +56,748 sh+$367.7K
  2. JANE STREET GROUPAdded · +42,134 sh+$273.0K
  3. BAILARDNew · +24,624 sh+$159.6K
  4. Quadrature Capital LtdNew · +24,014 sh+$155.6K
  5. UBS Group AGAdded · +21,150 sh+$137.1K

Biggest sellers

  1. BRIDGEWAY CAPITAL MANAGEMENTTrimmed · -137,268 sh-$889.5K
  2. PERCEPTIVE ADVISORSTrimmed · -99,996 sh-$648.0K
  3. J. GoldmanSold out · -81,040 sh-$525.1K
  4. Ikarian CapitalTrimmed · -50,000 sh-$324.0K
  5. ACADIAN ASSET MANAGEMENTSold out · -44,288 sh-$287.0K

CPIX 13F holders ranked 1–32 of 32

Institutional investors reporting a position in CUMBERLAND PHARMACEUTICALS INC on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Ikarian Capital#1 · 503,153 sh$3.3M-9.0%
RENAISSANCE TECHNOLOGIES#2 · 478,263 sh$3.1M+1.6%
VANGUARD CAPITAL MANAGEMENT#3 · 379,478 sh$2.5M+4.9%
DIMENSIONAL FUND ADVISORS#4 · 233,305 sh$1.5M-15.6%
BOOTHBAY FUND MANAGEMENT#5 · 112,544 sh$729.3K-11.9%
GEODE CAPITAL MANAGEMENT#6 · 108,413 sh$702.6K-5.1%
PERCEPTIVE ADVISORS#7 · 96,982 sh$628.4K-50.8%
CITADEL ADVISORS#8 · 73,391 sh$475.6K+341.0%
BlackRock#9 · 63,547 sh$411.8K+11.7%
Bank of New York Mellon#10 · 58,458 sh$378.8K0.0%
JANE STREET GROUP#11 · 56,741 sh$367.7K+288.5%
VANGUARD FIDUCIARY#12 · 54,909 sh$355.8K+20.4%
STATE STREET#13 · 39,510 sh$256.0K0.0%
UBS Group AG#14 · 26,339 sh$170.7K+407.6%
BRIDGEWAY CAPITAL MANAGEMENT#15 · 26,200 sh$169.8K-84.0%
BAILARD#16 · 24,624 sh$159.6KNew
Quadrature Capital Ltd#17 · 24,014 sh$155.6KNew
TWO SIGMA INVESTMENTS#18 · 23,981 sh$155.4K+116.3%
NORTHERN#19 · 21,953 sh$142.3K+12.0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP#20 · 20,252 sh$131.2K0.0%
Cresset Asset Management#21 · 19,475 sh$126.2K0.0%
XTX Topco Ltd#22 · 14,118 sh$91.5K-41.2%
SIMPLEX TRADING#23 · 4,544 sh$29.4KNew
MORGAN STANLEY#24 · 3,261 sh$21.1K0.0%
Capital Advisors, Ltd.#25 · 437 sh$3.0K0.0%
Institute for Wealth Management#26 · 352 sh$2.3KNew
OSAIC#27 · 200 sh$1.3KNew
Tower Research Capital (TRC)#28 · 191 sh$1.2KNew
WELLS FARGO & COMPANY#29 · 100 sh$648.000.0%
BARCLAYS PLC#30 · 48 sh$311.00New
FMR#31 · 21 sh$136.00New
HUNTINGTON NATIONAL BANK#32 · 1 sh$6.000.0%

Funds that sold out of CPIX in Q2 2026 (5)

Held CPIX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held CPIX in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
J. Goldman81,040 sh$263.4K
ACADIAN ASSET MANAGEMENT44,288 sh$143.0K
Marex Group plc36,423 sh$118.4K
Caitong International Asset Management , Ltd2 sh$6.00
ROYAL BANK OF CANADA127 sh$0.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.